Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 52–52 | Cite as

Azathioprine/rituximab/tacrolimus

Post-transplant lymphoproliferative disorder and bowel perforation: case report
Case report
  • 25 Downloads

Reference

  1. Sullivan BJ, et al. Treatment dilemma for survivors of rituximab-induced bowel perforation in the setting of post-transplant lymphoproliferative disorder. BMJ Case Reports 11: e226666, No. 1, 13 Dec 2018. Available from: URL: http://doi.org/10.1136/bcr-2018-226666 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations